Enhanced antitumor activity of bovine lactoferrin through immobilization onto functionalized nano graphene oxide: an in vitro/in vivo study

References

• Akbari A, Akbarzadeh A, Rafiee Tehrani M, et al. (2020). Development and characterization of nanoliposomal hydroxyurea against BT-474 breast cancer cells. Adv Pharm Bull 10:39–45.
   PubMed Web of Science ®Google Scholar
• Amiri B, Ahmadvand H, Farhadi A, et al. (2018). Delivery of vinblastine-containing niosomes results in potent in vitro/in vivo cytotoxicity on tumor cells. Drug Dev Ind Pharm 44:1371–6.
   PubMed Web of Science ®Google Scholar
• Arias M, Hilchie A, Haney EF, et al. (2017). Anticancer activities of bovine and human lactoferricin-derived peptides. Biochem Cell Biol 95:91–8.
   PubMed Web of Science ®Google Scholar
• Bao H, Pan Y, Ping Y, et al. (2011). Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small 7:1569–78.
   PubMed Web of Science ®Google Scholar
• Chea C, Miyauchi M, Inubushi T, et al. (2018). Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma. PLoS One 13:e0191683.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu H, Zhao C, et al. (2014). One-step reduction and PEGylation of graphene oxide for photothermally controlled drug delivery. Biomaterials 35:4986–95.
   PubMed Web of Science ®Google Scholar
• Chiani M, Shokrgozar MA, Azadmanesh K, et al. (2017). Preparation, characterization, and in vitro evaluation of bleomycin-containing nanoliposomes. Chem Biol Drug Des 89:492–7.
   PubMed Web of Science ®Google Scholar
• Dasari S, Samy A, Narvekar P, et al. (2018). Polygodial analog induces apoptosis in LNCaP prostate cancer cells. Eur J Pharmacol 828:154–62.
   PubMed Web of Science ®Google Scholar
• EFSA. (2012). Scientific opinion on bovine lactoferrin. EFSA J 10:2701–27.
   Google Scholar
• Emadi F, Amini A, Gholami A, et al. (2017). Functionalized graphene oxide with chitosan for protein nanocarriers to protect against enzymatic cleavage and retain collagenase activity. Sci Rep 7:42258.
   PubMed Web of Science ®Google Scholar
• García-Montoya IA, Cendón TS, Arévalo-Gallegos S, et al. (2012). Lactoferrin a multiple bioactive protein: an overview. Biochim Biophys Acta 1820:226–36.
   PubMed Web of Science ®Google Scholar
• Gibbons J, Kanwar J, Kanwar R. (2015). Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer. BMC Cancer 15:425.
   PubMed Web of Science ®Google Scholar
• Guedes JP, Pereira CS, Rodrigues LR, et al. (2018). Bovine milk lactoferrin selectively kills highly metastatic prostate cancer PC-3 and osteosarcoma MG-63 cells in vitro. Front Oncol 8:200.
   PubMed Web of Science ®Google Scholar
• Hashemi M, Yadegari A, Yazdanpanah G, et al. (2016). Functionalized R9-reduced graphene oxide as an efficient nanoCarrier for hydrophobic drug delivery. RSC Adv 6:74072–84.
   Web of Science ®Google Scholar
• Hayes TG, Falchook GS, Varadhachary A. (2010). Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors. Invest New Drugs 28:156–62.
   PubMed Web of Science ®Google Scholar
• Jonasch E, Stadler WM, Bukowski RM, et al. (2008). Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma. Cancer 113:72–7.
   PubMed Web of Science ®Google Scholar
• Kazempour M, Namazi H, Akbarzadeh A, et al. (2019). Synthesis and characterization of PEG-functionalized graphene oxide as an effective pH-sensitive drug carrier. Artif Cells Nanomed Biotechnol 47:90–4.
   PubMed Web of Science ®Google Scholar
• Li D, Muller MB, Gilje S, et al. (2008). Processable aqueous dispersions of graphene nanosheets. Nat Nanotechnol 3:101–5.
   PubMed Web of Science ®Google Scholar
• Li D, Sakashita S, Morishita Y, et al. (2011). Binding of lactoferrin to IGBP1 triggers apoptosis in a lung adenocarcinoma cell line. Anticancer Res 31:529–34.
   PubMed Web of Science ®Google Scholar
• Li L, Tang FQ, Liu HY, et al. (2010). In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. ACS Nano 4:6874–82.
   PubMed Web of Science ®Google Scholar
• Liu Z, Robinson JT, Sun X, et al. (2008). PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 130:10876–7.
   PubMed Web of Science ®Google Scholar
• Lu T, Nong Z, Wei L, et al. (2020). Preparation and anti-cancer activity of transferrin/folic acid double-targeted graphene oxide drug delivery system. J Biomater Appl 35:15–27.
   PubMed Web of Science ®Google Scholar
• Onishi H, Machida Y, Koyama K. (2007). Preparation and in vitro characteristics of lactoferrin-loaded chitosan microparticles. Drug Dev Ind Pharm 33:641–7.
   PubMed Web of Science ®Google Scholar
• Pan S, Qi Z, Li Q, et al. (2019). Graphene oxide-PLGA hybrid nanofibres for the local delivery of IGF-1 and BDNF in spinal cord repair. Artif Cells Nanomed Biotechnol 47:650–63.
   Web of Science ®Google Scholar
• Qiang M, Pang X, Ma D, et al. (2020). Effect of membrane surface modification using chitosan hydrochloride and lactoferrin on the properties of astaxanthin-loaded liposomes. Molecules 25:610.
   PubMed Web of Science ®Google Scholar
• Singh K, Srivastava G, Talat M, et al. (2015). α-Amylase immobilization onto functionalized graphene nanosheets as scaffolds: its characterization, kinetics and potential applications in starch based industries. Biochem Biophys Rep 3:18–25.
   PubMedGoogle Scholar
• SreeHarsha N, Maheshwari R, Al-Dhubiab BE, et al. (2019). Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy. Int J Nanomedicine 14:7419–29.
   PubMed Web of Science ®Google Scholar
• Stankovich S, Dikin DA, Dommett GH, et al. (2006). Graphene-based composite materials. Nature 442:282–6.
   PubMed Web of Science ®Google Scholar
• Tsuda H, Kozu T, Iinuma G, et al. (2010). Cancer prevention by bovine lactoferrin: from animal studies to human trial. Biometals 23:399–409.
   PubMed Web of Science ®Google Scholar
• Tsuda H, Sekine K, Fujita K, et al. (2002). Cancer prevention by bovine lactoferrin and underlying mechanisms-a review of experimental and clinical studies. Biochem Cell Biol 80:131–6.
   PubMed Web of Science ®Google Scholar
• Villanueva PJ, Martinez A, Baca ST, et al. (2018). Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis. PLoS One 13:e0206467.
   PubMed Web of Science ®Google Scholar
• Wang B, Timilsena YP, Blanch E, et al. (2019). Lactoferrin: structure, function, denaturation and digestion. Crit Rev Food Sci Nutr 59:580–96.
   PubMed Web of Science ®Google Scholar
• Wang C, Feng L, Yang H, et al. (2012). Graphene oxide stabilized polyethylene glycol for heat storage. Phys Chem Chem Phys 14:13233–8.
   PubMed Web of Science ®Google Scholar
• Xu H, Fan M, Elhissi AM, et al. (2015). PEGylated graphene oxide for tumor-targeted delivery of paclitaxel. Nanomedicine 10:1247–62.
   PubMed Web of Science ®Google Scholar
• Xu XX, Jiang HR, Li HB, et al. (2010). Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin. J Dairy Sci 93:2344–50.
   PubMed Web of Science ®Google Scholar
• Xu Z, Wang S, Li Y, et al. (2014). Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel. ACS Appl Mater Interfaces 6:17268–76.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhu S, Wang M, et al. (2015). Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier. ACS Appl Mater Interfaces 7:1355–63.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Sato R, Kobayashi S, et al. (2008). The antiproliferative effect of bovine lactoferrin on canine mammary gland tumor cells. J Vet Med Sci 70:443–8.
   PubMed Web of Science ®Google Scholar
• Yang K, Feng L, Liu Z. (2015). The advancing uses of nano-graphene in drug delivery. Expert Opin Drug Deliv 12:601–12.
   PubMed Web of Science ®Google Scholar
• Zaaba NI, Foo KL, Hashim U, et al. (2017). Synthesis of graphene oxide using modified hummers method: solvent influence. Procedia Eng 184:469–77.
   Google Scholar
• Zhang Y, Lima CF, Rodrigues LR. (2015). In vitro evaluation of bovine lactoferrin potential as an anticancer agent. Int Dairy J 40:6–15.
   Web of Science ®Google Scholar
• Zhang L, Lu Z, Zhao Q, et al. (2011). Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small 7:460–4.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xia J, Zhao Q, et al. (2010). Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6:537–44.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Nicolau A, Lima CF, et al. (2014). Bovine lactoferrin induces cell cycle arrest and inhibits Mtor signaling in breast cancer cells. Nutr Cancer 66:1371–85.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zeng Z, Zhang W, et al. (2008). Lactotransferrin: a candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer 123:2065–72.
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhou B, Chan L, et al. (2017). Transferrin-functionalized nanographene oxide for delivery of platinum complexes to enhance cancer-cell selectivity and apoptosis-inducing efficacy. Int J Nanomedicine 12:5023–38.
   PubMed Web of Science ®Google Scholar